Management of toxin-related fulminant hepatitis in intensive care.

By Wittebole X.   Laterre P.F.  

Reanimation Urgences, Vol. 10, Iss. 4, 2001-06 ,pp. : 418-425

Elsevier

Access to resources Recommend Favorite

Rituximab therapy for hepatitis C virus‐associated cryoglobulinemic membranoproliferative glomerulonephritis

By  

Clinical Case Reports, Vol. 6, Iss. 2, 2018-02 ,pp. : 442-443

John Wiley & Sons Inc

Access to resources Recommend Favorite

Psoriatic Arthritis: Recognition and Management

By Bruce I.N.   Gladman D.D.  

BioDrugs, Vol. 9, Iss. 4, 1998-04 ,pp. : 271-278

Adis International

Access to resources Recommend Favorite

Spotlight on Peginterferon-α-2a (40 kD) Plus Ribavirin in the Management of Chronic Hepatitis C Mono-Infection†

By Keam Susan J.   Cvetković Risto S.  

BioDrugs, Vol. 23, Iss. 1, 2009-01 ,pp. : 63-68

Adis International

Access to resources Recommend Favorite

Efficacy of different second- and third-generation assays for detection of hepatitis C virus antibodies in plasma and sera also tested by polymerase chain reaction

By Pujol F.H.   Blitz-Dorfman L.   Leon G.   Monsalve F.   Echevarria J.M.   Liprandi F.  

Serodiagnosis and Immunotherapy in Infectious Disease, Vol. 7, Iss. 2, 1995-06 ,pp. : 51-54

Elsevier

Access to resources Recommend Favorite